Your session is about to expire
← Back to Search
Lithium vs Divalproex for Pediatric Bipolar Disorder (PBC Trial)
PBC Trial Summary
This trial will compare the effectiveness of lithium, divalproex, and placebo in treating bipolar I disorder in children and adolescents.
PBC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPBC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Who would be the ideal candidate for this clinical trial?
"This psychiatric clinical trial is testing a new intervention for manic disorder in children and adolescents aged 7-18. A total of 154 participants are needed for the study."
Is the target age group for this research over 20 years old?
"As this clinical trial only accepts patients that meet specific age requirements, the minimum age of 7 and maximum age of 18 years old."
Could you please explain the risks associated with this treatment?
"The safety of this treatment was scored a 3 by our team at Power. This is because the trial is currently in Phase 3, which suggests that there is both some evidence of efficacy and multiple rounds of data supporting safety."
Are people still being signed up for this experiment?
"Unfortunately, this trial is no longer enrolling patients. It was originally posted on March 1st 2001 but the listing was last updated over 15 years ago on February 22nd 2006. There are, however, many other trials (163 to be exact) that might have open spots for you."
Share this study with friends
Copy Link
Messenger